David Lockhart, ReCode Therapeutics CEO
Pfizer throws its weight behind LNP player eyeing mRNA treatments for CF, PCD
David Lockhart did not see the meteoric rise of messenger RNA and lipid nanoparticles coming.
Thanks to the worldwide fight against Covid-19, mRNA — the genetic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.